Hypoxia-inducible factor 1-alpha enhances the Secretome to Rejuvenate Adult Cardiosphere Derived Cells
After cardiac injury, endogenous repair mechanisms are ineffective. However, cell-based therapies provide a promising clinical intervention based on their ability to restore and remodel injured myocardium due to their paracrine factors. Recent clinical trials have demonstrated that adult cardiosphere-derived cell (aCDC) therapy is safe for the treatment of ischemic heart failure, although with limited regenerative potential. The limited efficiency of CDCs post-myocardial infarction (MI) is attributed to the inferior quality of their secretome.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Progyaparamita Saha, MinJung Kim, Antariksh Tulshyan, Yin Guo, Rachana Mishra, Deqiang Li, Curt.I. Civin, Sunjay Kaushal, Sudhish Sharma Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Gastroschisis Repair | Heart | Heart Attack | Heart Failure